What is the Future of Immunophenotyping in Cancer Care?
Advances in immunophenotyping are likely to enhance its accuracy and applicability. Innovations such as multiparametric flow cytometry, which can analyze multiple markers simultaneously, and integration with genomic and proteomic data, are paving the way for more comprehensive cancer profiling. This will not only improve diagnostic precision but also enable more effective and personalized treatment strategies.
